- Home
- BFLY vs PROK Comparison
BFLY vs PROK Comparison
Compare BFLY & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFLY | PROK |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 871.5M | 417.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BFLY | PROK |
|---|---|---|
| Price | $3.50 | $2.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $3.50 | ★ $7.40 |
| AVG Volume (30 Days) | ★ 6.0M | 1.4M |
| Earning Date | 10-31-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $88,447,000.00 | $744,000.00 |
| Revenue This Year | $13.77 | $918.66 |
| Revenue Next Year | $16.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.04 | N/A |
| 52 Week Low | $1.32 | $0.46 |
| 52 Week High | $4.98 | $7.13 |
Technical Indicators
Market Signals| Indicator | BFLY | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 65.09 | 49.07 |
| Support Level | $2.96 | $2.06 |
| Resistance Level | $3.61 | $2.59 |
| Average True Range (ATR) | 0.23 | 0.18 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 90.28 | 47.46 |
Price Performance
Historical ComparisonAbout BFLY Butterfly Network Inc.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.